News

AIChE Elects UH Engineer as Vice Chair for Catalysis and Reaction Engineering Division

By: 

Natalie Thayer

Lars Grabow, assistant professor of chemical and biomolecular engineering at the Cullen College, was recently elected as second vice chair for the Catalysis and Reaction Engineering (CRE) division of the American Institute of Chemical Engineers (AIChE).

As a leading worldwide organization for chemical engineering professionals, AIChE’s vision is to provide value to the field by promoting chemical engineers’ professional and personal growth and by applying chemical expertise to meet global societal needs. AIChE boasts more than 50,000 members from over 100 countries. Members are connected with a vast network of renowned colleagues, provided with unique learning opportunities, and gain access to established and novel chemical engineering processes and methods. The CRE division, which focuses on catalysis, industrial and engineering chemistry, fuel chemistry and petroleum, is the third largest division of AIChE.

In his role as second vice chair for the CRE division, Grabow will be responsible for the CRE Travel Awards, which provide graduate students with travel assistance to present their research at the annual AIChE meeting. He will select the judges to review applications, select the 20 strongest graduate students to receive the awards and present the awards to the winners at the 2016 CRE annual meeting in San Francisco, Calif.

Grabow will be committed to the AIChE leadership team for four years. After serving as second vice chair, he will move into the role of vice chair in 2017, chair in 2018 and past-chair in 2019.

To learn more about AIChE’s CRE division, please visit http://www.aiche.org/community/divisions/catalysis-and-reaction-engineering-division-cre.

Faculty: 

Department/Academic Programs: 

Related News Stories

University of Houston Partners with AuraVax Therapeutics on COVID-19 Vaccine

Navin Varadarajan, M.D. Anderson Professor of Chemical and Biomolecular Engineering, has created a nasal vaccine for COVID-19 and a company to market it in partnership with the University of Houston.

The University of Houston has entered into an exclusive license option agreement with AuraVax Therapeutics Inc., a Houston, TX based biotech company developing novel vaccines to help patients defeat debilitating respiratory diseases such as COVID-19. Under terms of the agreement, AuraVax has the option to exclusively license a new intranasal COVID-19 vaccine technology developed by Dr. Navin Varadarajan, M.D. Anderson Professor of Chemical and Biomolecular Engineering.

Faster swimming bacteria could help with spills

Narendra Dewangan, a graduate student of Dr. Jacinta Conrad, has completed work with the Conrad Research Group on how faster swimming bacteria could be used to help with removal of pollutants.

A new paper and research from the Conrad Research Group of the Department of Chemical and Biomolecular Engineering at the University of Houston’s Cullen College of Engineering looks at how bacteria could be used to help with removal of pollutants, like in oil spills and wastewater treatment.

Rapid tests for COVID-19 now, other diseases later the goal for Kourentzi

Dr. Katerina Kourentzi, Research Associate Professor of Chemical and Biomolecular Engineering, is developing a saliva-based lateral flow assay rapid test for COVID-19 detection. The test strips for the assay are designed using the Biodot XYZ3060 Dispensing Platform.

The development of point-of-care tests – and as of late, for COVID-19 – has been the primary focus of Dr. Katerina Kourentzi, Research Associate Professor of Chemical and Biomolecular Engineering in the William A. Brookshire Department of Chemical and Biomolecular Engineering at the University of Houston's Cullen College of Engineering.